Refusal to Fill: Balancing Diversion Risk and Patient Care

A pharmacist-in-charge who refuses to fill a controlled substance prescription is not making a routine service decision. The refusal sits between two federal obligations pulling in opposite directions: the corresponding responsibility to prevent diversion under 21 CFR 1306.04, and the duty not to deny pharmacy services to a patient because of a protected characteristic, including a disability such as opioid use disorder, under Title III of the Americans with Disabilities Act. A pharmacy that mishandles the balance risks enabling diversion on one side or facing a discrimination complaint on the other, and the same prescription can produce either outcome depending on how the refusal is made and documented.

Corresponding Responsibility Under 21 CFR 1306.04

21 CFR 1306.04(a) places responsibility for proper prescribing on the practitioner, but states that a corresponding responsibility rests with the pharmacist who fills the prescription. A pharmacist who knowingly dispenses a prescription issued outside the usual course of professional treatment is subject to the same penalties that apply to the prescriber. The Drug Enforcement Administration and reviewing courts apply the three part test set out in Holiday CVS, L.L.C., 77 Fed. Reg. 62,316 (Oct. 12, 2012): a controlled substance was dispensed, a red flag of diversion was present or should have been recognized, and the red flag was not resolved before dispensing. A pharmacy that dispenses without resolving a red flag faces exposure under this standard regardless of intent, exposure that can escalate to a DEA order to show cause or, in urgent cases, an immediate suspension order.

Red Flags and the Duty to Resolve Them

Red flags recognized in DEA enforcement decisions and pharmacy board guidance include cash payment for a prescription normally covered by insurance, a prescriber and patient located an unusual distance apart, early refill requests, a drug combination associated with diversion, and a dose or quantity outside the range typically prescribed for the diagnosis. Section 1306.04 does not instruct a pharmacist to refuse every prescription that carries a red flag. It requires the pharmacist to resolve the concern, through a call to the prescriber, a review of the patient's dispensing history, or another documented step, before dispensing. A refusal to fill is lawful, and often required, when a red flag cannot be resolved. A blanket policy against filling a class of drug, or against a category of patient, applied without an individualized review of the specific prescription, does not satisfy that standard and invites separate exposure the next time a DEA inspection reviews the pharmacy's refusal log.

Patient Access and Anti-Discrimination Exposure

A pharmacy is a place of public accommodation under 28 CFR 36.104, which lists pharmacies among the service establishments covered by Title III of the Americans with Disabilities Act. The Department of Justice has stated that a person with opioid use disorder who takes a medication prescribed and supervised by a licensed provider is not engaged in the illegal use of drugs and remains protected from disability discrimination. A pharmacist-in-charge who refuses medication for opioid use disorder, or any controlled substance, based on a patient's diagnosis or history rather than an unresolved concern about the specific prescription in front of the pharmacist, risks a discrimination complaint on top of any board of pharmacy inquiry into the refusal itself.

A refusal to fill that is not tied to a specific, unresolved red flag on the prescription in front of the pharmacist is difficult to defend as diversion prevention and simple to characterize as denial of care.

Why Early Legal Counsel Is Critical

It is critical that a pharmacist-in-charge involve counsel as soon as a refusal to fill draws a complaint, whether from a patient alleging discrimination or a board of pharmacy inquiring about a pattern of refusals. Counsel who has guided pharmacies through an order to show cause response can help compile the specific red flag, the steps taken to resolve it, and the basis for the final decision, before memories fade or the file becomes the subject of a formal proceeding. A pattern of refusals combined with other findings can also support the imminent danger standard behind an immediate suspension order, so a pharmacy should not wait until regulators or a patient's attorney open an inquiry to build that record.

How Health Law Alliance Can Help

Health Law Alliance represents pharmacies navigating refusal to fill decisions and the DEA and board of pharmacy inquiries that can follow, as part of the firm's DEA defense practice. If your pharmacy is weighing a refusal to fill or facing a complaint tied to one, contact us for a free, confidential consultation.